Biocon Q3FY26 results: Revenue up 9%, net profit rises on generics push ...Middle East

Board gives in-principle nod to make Biocon Biologics a wholly owned subsidiary as Q3 net profit climbs to Rs 143.8 crore

Hence then, the article about biocon q3fy26 results revenue up 9 net profit rises on generics push was published today ( Thursday 12/02/2026 - 06:50 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biocon Q3FY26 results: Revenue up 9%, net profit rises on generics push )

Also on site :

• Sisi holds meeting with CBE governor, as Egypt’s foreign reserves hit record $52.6 billion
• Africa: Africa's Regional Blocs Must Prevent a Silent Scramble for Critical Minerals
• Big Tech Is Raiding the Energy Sector to Power the AI Boom